Cargando…

Agoitrous Graves’ Hyperthyroidism with Markedly Elevated Thyroid Stimulating Immunoglobulin Titre displaying Rapid Response to Carbimazole with Discordant Thyroid Function

We characterize the clinical and laboratory characteristics of 5 patients with Graves’ thyrotoxicosis whose serum free thyroxine (fT4) concentration decreased unexpectedly to low levels on conventional doses of carbimazole (CMZ) therapy. The initial fT4 mean was 40.0 pM, range 25–69 pM. Thyroid volu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kon, Yin Chian, Ping Lim, Brenda Su, Lee, Yingshan, Aw, Swee Eng, Yoke Wong, Yoko Kin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Journal of the ASEAN Federation of Endocrine Societies 2020
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784233/ https://www.ncbi.nlm.nih.gov/pubmed/33442195 http://dx.doi.org/10.15605/jafes.035.02.13

Ejemplares similares

Severe Hypothyroxinemia in a Young Adult with Carbimazole-Treated T3-Predominant Graves’ Hyperthyroidism, Reversed with L-Thyroxine Loading Immediately Post-Total Thyroidectomy
por: Chiang, Brenda, et al.
Publicado: (2021)

Pharmacodynamic Response to Anti-thyroid Drugs in Graves' Hyperthyroidism
por: Abbara, Ali, et al.
Publicado: (2020)

Carbimazole-induced cholestatic hepatitis in Graves’ disease
por: Kota, Sunil K., et al.
Publicado: (2013)

Radioiodine Thyroid Ablation in Graves’ Hyperthyroidism: Merits and Pitfalls
por: Nwatsock, J. F., et al.
Publicado: (2012)

Psychosis Following Carbimazole-induced Acute Alteration of Hyperthyroid Status
por: Gowda, Guru S., et al.
Publicado: (2017)

Thyroid Function after Subtotal Thyroidectomy in Patients with Graves' Hyperthyroidism
por: Limonard, E. J., et al.
Publicado: (2012)

Weight homeostasis & its modulators in hyperthyroidism before & after treatment with carbimazole
por: Dutta, Pinaki, et al.
Publicado: (2012)

Anti-Thyroid Drugs-Related Myopathy: Is Carbimazole the Real Culprit?
por: Tsang, Chiu Chi, et al.
Publicado: (2015)

Timing of Graves’ Hyperthyroidism Management in Pregnant Women: Impact on the Infant Thyroid Volume
por: Mikołajczak, Aleksandra, et al.
Publicado: (2022)

A Review of Testing for Distinguishing Hashimoto’s Thyroiditis in the Hyperthyroid Stage and Grave’s Disease
por: Liu, Yutong, et al.
Publicado: (2023)

Radioiodine therapy in patients with Graves’ disease and the effects of prior carbimazole therapy
por: Karyampudi, Arun, et al.
Publicado: (2014)

A rare case of carbimazole-induced hepatitis in a patient with Graves’ disease
por: Burgin, Sarah, et al.
Publicado: (2015)

Measurement of oxidative stress and total antioxidant capacity in hyperthyroid patients following treatment with carbimazole and antioxidant
por: Sultana, Dr. Razia, et al.
Publicado: (2021)

SUN-510 Prolonged RAIA Induced Thyroiditis After 131 I Therapy for Graves’ Hyperthyroidism
por: Aljaberi, Asma Khaled, et al.
Publicado: (2020)

A Unique Presentation of Metastatic Follicular Thyroid Cancer Associated with Hyperthyroidism and an Active Graves’ Orbitopathy
por: Al-Jundi, Mohammad, et al.
Publicado: (2021)

Iatrogenic Hyperthyroidism With Recurrent Functioning Thyroid Tissue 40 Years After Thyroidectomy for Graves’ Disease
por: Penquite, Sara Ashlyn, et al.
Publicado: (2021)

Adult mouse and human organoids derived from thyroid follicular cells and modeling of Graves’ hyperthyroidism
por: van der Vaart, Jelte, et al.
Publicado: (2021)

THU665 Unilateral Graves’ Disease In A Bilobar Thyroid Gland: Unusual Cause Of Hyperthyroidism
por: Hamid Alaybaa, Khaled, et al.
Publicado: (2023)

Unilateral Graves’ Disease in a Bilobar Thyroid Gland: A Very Unusual Cause of Hyperthyroidism
por: Alaybaa, Khaled, et al.
Publicado: (2023)

Thyroid Hemiagenesis Associated with Hyperthyroidism
por: Gurleyik, Gunay, et al.
Publicado: (2015)

Carbimazole-induced agranulocytosis
por: Mohan, Anisha, et al.
Publicado: (2015)

Carbimazole induced nephrotoxicity
por: Rajesh, Reza, et al.
Publicado: (2021)

Carbimazole induced rhabdomyolysis
por: O’Donnell, Niamh, et al.
Publicado: (2021)

Carbimazole-Resistant Grave’s Thyrotoxicosis is a Diagnostic and Therapeutic Dilemma, Case Report with Literature Review
por: Ata, Fateen, et al.
Publicado: (2023)

Severe Neutropenia and Hepatotoxicity After Carbimazole Drug Therapy for Hyperthyroidism in a Pediatric Patient: A Case Report
por: Alnajar, Lina I., et al.
Publicado: (2023)

Peripheral blood lymphocyte apoptosis and its relationship with thyroid function tests in adolescents with hyperthyroidism due to Graves' disease
por: Klatka, Maria, et al.
Publicado: (2012)

FRI549 The See-Saw Theory - Hypothyroidism Due To Hashimoto's Thyroiditis Followed By Hyperthyroidism Due To Graves' Disease
por: Sharma, Pranjali
Publicado: (2023)

The prevalence of thyroid cancer in patients with hyperthyroidism
por: Kunjumohamed, Fathimabeebi P., et al.
Publicado: (2015)

Carbimazole (Neo-Mercazole) in Thyrotoxicosis
por: Boyd, M. W. J.
Publicado: (1959)

Carbimazole Embryopathy and Choanal Atresia
por: Raveenthiran, V
Publicado: (2014)

Persistent Graves’ hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report
por: Ohara, Nobumasa, et al.
Publicado: (2017)

The importance of an individual approach to Graves’ hyperthyroidism
por: Bednarczuk, Tomasz
Publicado: (2015)

Alternating hyperthyroidism and hypothyroidism in Graves’ disease
por: Wong, Mimi, et al.
Publicado: (2018)

New Therapeutic Horizons for Graves’ Hyperthyroidism
por: Lane, Laura C, et al.
Publicado: (2020)

R-CHOP-Associated Graves' Hyperthyroidism
por: Mora, Natalie, et al.
Publicado: (2019)

Toward Ultimate Care for Graves’ Hyperthyroidism
por: Azizi, Fereidoun, et al.
Publicado: (2019)

The Grave Hematologic and Hepatic Effects of Hyperthyroidism
por: Ahmad, Sara Miriam, et al.
Publicado: (2021)

The Clinical and Thyroid Function Studies of Lymphocytic Thyroiditis with Spontaneously Resolving Hyperthyroidism: Comparison to Subacute Thyroiditis
por: Koh, Eun Hee, et al.
Publicado: (1986)

Role of Maternal Thyroid-Stimulating Immunoglobulin in Graves' Disease for Predicting Perinatal Thyroid Dysfunction
por: Cui, Yiwen, et al.
Publicado: (2019)

Thyroid Drugging in Graves' Disease
por: Chaudhuri, R. N.
Publicado: (1941)

Cannot write session to /tmp/vufind_sessions/sess_jcd8gf1nrg1s09osd6tqsrjk0g